Strategic Application of Epigenetic Regulators for Efficient Neuronal Reprogramming of Human Fibroblasts

Int J Stem Cells. 2023 May 30;16(2):156-167. doi: 10.15283/ijsc22183. Epub 2023 Feb 28.

Abstract

Background and objectives: Cellular reprogramming in regenerative medicine holds great promise for treating patients with neurological disorders. In this regard, small molecule-mediated cellular conversion has attracted special attention because of its ease of reproducibility, applicability, and fewer safety concerns. However, currently available protocols for the direct conversion of somatic cells to neurons are limited in clinical application due of their complex nature, lengthy process, and low conversion efficiency.

Methods and results: Here, we report a new protocol involving chemical-based direct conversion of human fibroblasts (HF) to matured neuron-like cells with a short duration and high conversion efficiency using temporal and strategic dual epigenetic regulation. In this protocol, epigenetic modulation by inhibition of histone deacetylase and bromodomain enabled to overcome "recalcitrant" nature of adult fibroblasts and shorten the duration of neuronal reprogramming. We further observed that an extended epigenetic regulation is necessary to maintain the induced neuronal program to generate a homogenous population of neuron-like cells.

Conclusions: Therefore, our study provides a new protocol to produce neurons-like cells and highlights the need of proper epigenetic resetting to establish and maintain neuronal program in HF.

Keywords: Direct reprogramming; Dual epigenetic modification; Neurons; Patient-specific; Regenerative medicine.

Grants and funding

Acknowledgments The work was conducted with the SKKU cooperative fund (S-2022-2128-000).